Now showing items 321-322 of 322
Empagliflozin improves cardiorespiratory fitness in type 2 diabetes: Translational implications
(NRC Research Press, 2018-11)
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to prevent heart failure and reduce cardiovascular death in patients with type 2 diabetes (T2DM) and cardiovascular disease (CVD). Whether or not SGLT2 ...
Concurrent validity of the GAITRite electronic walkway and the 10-meter walk test for measurement of walking speed after stroke
BACKGROUND: Walking speed is used to assess functional status, predict recovery, prescribe exercise, and track functional progress after stroke. Determining concurrent validity ensures that results from different tests ...